Fas Expression on Peritoneal Macrophages during Continuous Ambulatory Peritoneal Dialysis Peritonitis

Figures & data

Figure 1. Macrophages were identified and gated using forward scatter versus side scatter dot plot profiles.

Figure 2. Representative FACS histogram for the expression of CD95 on macrophages from (A) healthy control, (B) CAPD patient with peritonitis, and (C) CAPD patient without peritonitis.

Table 1 Expression percentage of CD95, CD54, CD25, and CD69 on macrophages in patients with CAPD peritonitis and normal control (NC)

Case	NC (n  =  11)	CAPD peritonitis (n  =  16)	p
Sex (male/female)	6/5	9/7	NS
Age (years)	72 ± 34	67 ± 24	NS
CD95/CD3 (%)	33.2 ± 11.9	56 ± 13.2	< 0.001
CD54/CD3 (%)	19.4 ± 3.7	35 ± 7.8	< 0.001
CD25/CD3 (%)	6.8 ± 1.9	11 ± 2.3	< 0.001
CD69/CD3 (%)	1.4 ± 1.2	6 ± 0.9	NS
CD95/CD56 (%)	63.4 ± 15.8	89 ± 8.7	< 0.001
CD54/CD56 (%)	54 ± 6.0	92 ± 9.5	< 0.001
CD25/CD56 (%)	1.2 ± 0.6	7 ± 0.9	NS
CD69/CD56 (%)	20.8 ± 0.5	23 ± 3.2	NS

Values are expressed as median ± SD.

Table 2 The expression percentage of CD95, CD54, CD25, and CD69 on macrophages in seven CAPD peritonitis patients, compared to nine CAPD patients without peritonitis

Case	No peritonitis (n  =  9)	Peritonitis (n  =  7)	p
Sex (male/female)	5/4	4/3	NS
Age (years)	69 ± 31	71 ± 28	NS
CD95/CD3 (%)	45 ± 8.3	65 ± 9.8	< 0.001
CD54/CD3 (%)	31 ± 4.8	40 ± 3.8	NS
CD25/CD3 (%)	9 ± 1.4	12 ± 1.3	NS
CD69/CD3 (%)	6 ± 0.8	7 ± 1.2	NS
CD95/CD56 (%)	83 ± 6.5	92 ± 7.3	NS
CD54/CD56 (%)	82 ± 9.9	98 ± 7.5	NS
CD25/CD56 (%)	6 ± 0.3	7 ± 0.5	NS
CD69/CD56 (%)	21 ± 5.3	24 ± 4.5	NS

Values are expressed as median ± SD.

Figure 3. Expression percentage of CD95 on macrophages (mean ± SD) among healthy controls (HC), CAPD patients without peritonitis (non-peritonitis), and CAPD patients with peritonitis.